Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
1.050
+0.020 (1.94%)
Dec 5, 2025, 4:00 PM EST - Market closed
Context Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 76.94 | 94.43 | 14.45 | 35.5 | 49.64 | 0.29 | Upgrade
|
| Cash & Short-Term Investments | 76.94 | 94.43 | 14.45 | 35.5 | 49.64 | 0.29 | Upgrade
|
| Cash Growth | -9.27% | 553.50% | -59.29% | -28.48% | 16976.13% | 28.27% | Upgrade
|
| Prepaid Expenses | 1.92 | 3.47 | 1.6 | 2.36 | 1.62 | 0.01 | Upgrade
|
| Total Current Assets | 79.06 | 97.9 | 16.05 | 37.85 | 51.26 | 0.3 | Upgrade
|
| Property, Plant & Equipment | 0.17 | 0.23 | 0.02 | 0.08 | - | - | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | - | 0.12 | Upgrade
|
| Other Long-Term Assets | - | - | - | 0.03 | 0.05 | 0.05 | Upgrade
|
| Total Assets | 79.23 | 98.13 | 16.06 | 37.97 | 51.31 | 0.47 | Upgrade
|
| Accounts Payable | 2.72 | 1.45 | 2.38 | 0.94 | 1.83 | 2.71 | Upgrade
|
| Accrued Expenses | 3.16 | 1.14 | 1.8 | 2.13 | 1.12 | 0.96 | Upgrade
|
| Short-Term Debt | - | - | - | - | - | 5.83 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | - | 0.06 | Upgrade
|
| Current Portion of Leases | 0.12 | 0.11 | - | 0.06 | - | - | Upgrade
|
| Other Current Liabilities | 0.03 | 0.05 | 0.01 | 0.08 | 0.09 | - | Upgrade
|
| Total Current Liabilities | 6.04 | 2.75 | 4.19 | 3.21 | 3.03 | 9.55 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 0.07 | Upgrade
|
| Long-Term Leases | 0.02 | 0.11 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | 0.03 | Upgrade
|
| Total Liabilities | 6.06 | 2.86 | 4.19 | 3.21 | 3.03 | 9.65 | Upgrade
|
| Common Stock | 0.09 | 0.09 | 0.02 | 0.02 | 0.02 | 0 | Upgrade
|
| Additional Paid-In Capital | 190.96 | 189.96 | 79.91 | 78.83 | 77.51 | 1.88 | Upgrade
|
| Retained Earnings | -117.88 | -94.78 | -68.05 | -44.09 | -29.25 | -18.8 | Upgrade
|
| Total Common Equity | 73.17 | 95.27 | 11.87 | 34.76 | 48.27 | -16.92 | Upgrade
|
| Shareholders' Equity | 73.17 | 95.27 | 11.87 | 34.76 | 48.27 | -9.18 | Upgrade
|
| Total Liabilities & Equity | 79.23 | 98.13 | 16.06 | 37.97 | 51.31 | 0.47 | Upgrade
|
| Total Debt | 0.14 | 0.22 | - | 0.06 | - | 5.95 | Upgrade
|
| Net Cash (Debt) | 76.8 | 94.21 | 14.45 | 35.44 | 49.64 | -5.66 | Upgrade
|
| Net Cash Growth | -9.18% | 551.98% | -59.23% | -28.59% | - | - | Upgrade
|
| Net Cash Per Share | 0.84 | 1.61 | 0.91 | 2.22 | 17.52 | -2.76 | Upgrade
|
| Filing Date Shares Outstanding | 91.88 | 89.7 | 15.97 | 15.97 | 15.97 | 0.33 | Upgrade
|
| Total Common Shares Outstanding | 91.88 | 89.7 | 15.97 | 15.97 | 15.97 | 0.33 | Upgrade
|
| Working Capital | 73.02 | 95.15 | 11.86 | 34.65 | 48.22 | -9.25 | Upgrade
|
| Book Value Per Share | 0.80 | 1.06 | 0.74 | 2.18 | 3.02 | -51.00 | Upgrade
|
| Tangible Book Value | 73.17 | 95.27 | 11.87 | 34.76 | 48.27 | -16.92 | Upgrade
|
| Tangible Book Value Per Share | 0.80 | 1.06 | 0.74 | 2.18 | 3.02 | -51.00 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.